Identification of a Lox+ fibroblast subset provides a potential therapeutic target for interstitial fibrosis in diabetic heart disease.
This study revealed the heterogeneity of cardiac fibroblasts in diabetic mice for the first time. Fibroblasts with high expression of Lox (cluster 4 fibroblasts) were identified to play a crucial role in fibrosis in diabetic heart disease. The findings of this study may provide a possible therapeutic target for interstitial fibrosis.
Li et al. (Wed,) studied this question.